Dcf Advisers, LLC Incyte Corp Transaction History

Dcf Advisers, LLC

$177 Million
Q4 2024

A detailed history of Dcf Advisers, LLC transactions in Incyte Corp stock. As of the latest transaction made, Dcf Advisers, LLC holds 48,500 shares of INCY stock, worth $3.39 Million. This represents 1.89% of its overall portfolio holdings.

Number of Shares

48,500

Previous 48,250 0.52%

Holding current value

$3.39 Million

Previous $3.19 Million 5.02%

% of portfolio

1.89%

Previous 1.32%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$65.08 - $83.38 $16,270 - $20,845	250 Added 0.52%	48,500 $3.35 Million
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $186,322 - $222,982	-3,250 Reduced 6.31%	48,250 $3.19 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $508,950 - $599,310	9,000 Added 21.18%	51,500 $2.93 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $104,320 - $128,380	-2,000 Reduced 4.49%	42,500 $2.67 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $231,080 - $263,720	4,000 Added 9.88%	44,500 $2.57 Million
Q2 2023 Aug 09, 2023	SELL	$60.95 - $75.51 $121,900 - $151,020	-2,000 Reduced 4.71%	40,500 $2.52 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $105,345 - $129,015	-1,500 Reduced 3.41%	42,500 $3.07 Million
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $99,270 - $124,770	-1,500 Reduced 3.3%	44,000 $3.34 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $1.62 Million - $1.95 Million	-24,500 Reduced 35.0%	45,500 $3.61 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $618,030 - $756,180	9,000 Added 14.75%	70,000 $4.82 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $319,480 - $350,120	-4,000 Reduced 6.15%	61,000 $5.13 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $190,050 - $251,250	2,500 Added 4.0%	65,000 $5.28 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $201,850 - $244,250	2,500 Added 4.17%	62,500 $5.44 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $127,604 - $164,535	1,500 Added 2.56%	60,000 $5.38 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $96,434 - $141,609	-1,300 Reduced 2.17%	58,500 $6.08 Million
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $935,064 - $1.27 Million	14,800 Added 32.89%	59,800 $4.38 Million
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $3.29 Million - $4.31 Million	45,000 New	45,000 $3.93 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account